COVID-19-Related Mesoblast Limited presented 90-day survival outcomes from the 222-patient trial of remestemcel-L in ventilator-dependent COVID-19 patients with moderate/severe acute respiratory distress syndrome (ARDS). The data demonstrated that two doses of the drug at days 3-5 provided durable survival benefit through at least 90 days in the subgroup of patients under 65 years of age. RedHill Biopharma announced that […]

Earlier this year, the Federal Trade Commission’s (FTC) posed a roadblock in the path of sequencing giant Illumina’s $7.1 billion proposed acquisition of Grail, a healthcare company focusing on early cancer detection, and importantly, a 2016 spin-out from the former. Right now, the European Commission (EC) is also investigating the soundness of this deal. The justification provided by […]

Cartesian Therapeutics is a clinical stage biotechnology company headquartered in Gaithersburg, MD. Although it has just 20 employees, the company performs all its preclinical and regulatory work and clinical operations in-house. A few years ago, Cartesian also built a GMP manufacturing facility from the ground up. That gives the company its own quality management system […]